U.S. FDA approves Sanofi's diabetes drug Toujeo
February 25, 2015 at 20:44 PM EST
Feb 25 (Reuters) - U.S. health regulators on Wednesday approved Sanofi's diabetes drug Toujeo, a more potent follow-up to the French drugmaker's top-selling insulin product Lantus.
